Zachariah Jonasson, Ph.D. is recorded as CFO at Absci Corp (ABSI) since August 31, 2023. Absci Corp reported in an 8-K filed August 14, 2023 that Zachariah Jonasson, Ph.D. resigned as Board of Directors, effective December 31, 2023. Absci Corp reported in an 8-K filed August 14, 2023 that Zachariah Jonasson, Ph.D. was appointed Chief Business Officer, effective August 31, 2023. Absci Corp reported in an 8-K filed August 14, 2023 that Zachariah Jonasson, Ph.D. was appointed Chief Financial Officer, effective August 31, 2023. Zachariah Jonasson, Ph.D. has spoken on 1 earnings call and 2 other investor events across 1 company, most recently for Absci Corp on September 16, 2026. Absci Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Absci Corp includes Sean McClain (CEO and Board Member), Zachariah Jonasson (CFO), Matthew Weinstock (CTO) and 7 others.
“Dr. Jonasson will remain on the Board of Directors through December 31, 2023 and resign from all committees effective as of August 30, 2023.”
Absci Corp Form 8-K, filed August 14, 2023
· Read the filing
“On August 11, 2023, the Company's Board of Directors appointed Zachariah Jonasson, Ph.D. as the Company's Chief Financial Officer, Chief Business Officer and Treasurer, effective as of August 31, 2023.”
Absci Corp Form 8-K, filed August 14, 2023
· Read the filing
Zachariah Jonasson, Ph.D. on recent calls
“But which policy variable are you most focused on? Yeah, I think we're most focused on FDA. I mean, we're in the middle of our Phase I, II trial for pattern hair loss.”
“So, Zach, for people who are new to APSA, can you frame the long-term strategy for us and how you decide what stays on your balance sheet and you know versus what gets partner yeah absolutely and again thanks for having us um i've been involved with abcide since 2016 i used to manage a venture firm so i've been a…”
“Our strategic priority is executing the clinical development of ABS-201 in both AGA and endometriosis, given the significant potential return on investment these programs offer.”
